Member Bibliography/Bibliografía de Miembros
This page collects all the personal publications that CienciaPR members have uploaded to their profiles. You can also see all of the authors collected in these publications or all the keywords contained in these publications.
] “Caffeine activates a mechanosensitive Ca(2+) channel in human red cells.”, Cell Calcium, vol. 31, no. 5, pp. 189-200, 2002.
“The future of the National Immunization Survey.”, Am J Prev Med, vol. 20, no. 4 Suppl, pp. 84-5, 2001.
“Varicella vaccine exposure during pregnancy: data from the first 5 years of the pregnancy registry.”, Obstet Gynecol, vol. 98, no. 1, pp. 14-9, 2001.
“National, state, and urban area vaccination coverage levels among children aged 19-35 months--United States, 1998.”, MMWR CDC Surveill Summ, vol. 49, no. 9, pp. 1-26, 2000.
“Preparing for elimination of congenital Rubella syndrome (CRS): summary of a workshop on CRS elimination in the United States.”, Clin Infect Dis, vol. 31, no. 1, pp. 85-95, 2000.
“The eradication of rubella.”, JAMA, vol. 281, no. 6, pp. 561-2, 1999.
“Reported biomedical causes and associated medical conditions for mental retardation among 10-year-old children, metropolitan Atlanta, 1985 to 1987.”, Dev Med Child Neurol, vol. 39, no. 3, pp. 142-9, 1997.
“Childhood immunization registries.”, JAMA, vol. 275, no. 17, pp. 1312-3, 1996.
“Descriptive epidemiology of holoprosencephaly and arhinencephaly in metropolitan Atlanta, 1968-1992.”, Am J Med Genet, vol. 66, no. 3, pp. 320-33, 1996.
“Finding the causes of birth defects.”, N Engl J Med, vol. 331, no. 1, pp. 48-9, 1994.
“Prevention of folic acid-preventable spina bifida and anencephaly.”, Ciba Found Symp, vol. 181, pp. 212-23; discussion 223-31, 1994.
“The epidemiology of disasters and adverse reproductive outcomes: lessons learned.”, Environ Health Perspect, vol. 101 Suppl 2, pp. 131-6, 1993.
“Acyclovir in pregnancy registry: six years' experience. The Acyclovir in Pregnancy Registry Advisory Committee.”, Obstet Gynecol, vol. 79, no. 1, pp. 7-13, 1992.
“Birth prevalence study of the Apert syndrome.”, Am J Med Genet, vol. 42, no. 5, pp. 655-9, 1992.
“The interaction between dysmorphology and epidemiology: methodologic issues of lumping and splitting.”, Teratology, vol. 45, no. 2, pp. 133-8, 1992.
“Maternal diabetes: the risk for specific birth defects.”, Eur J Epidemiol, vol. 8, no. 4, pp. 503-8, 1992.
“Registries of birth defects and genetic diseases.”, Pediatr Clin North Am, vol. 39, no. 1, pp. 65-77, 1992.
“Trends in rates of multiple vascular disruption defects, Atlanta, 1968-1989: is there evidence of a cocaine teratogenic epidemic?”, Teratology, vol. 45, no. 6, pp. 647-53, 1992.
“International collaboration in a cluster investigation.”, Am J Public Health, vol. 81, no. 8, pp. 1077-8, 1991.
“Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study.”, Pediatrics, vol. 85, no. 1, pp. 1-9, 1990.
“Effect of environmental agents on pregnancy outcomes: disturbances of prenatal growth and development.”, Med Clin North Am, vol. 74, no. 2, pp. 279-90, 1990.
“Potential human teratogenicity of frequently prescribed drugs.”, Obstet Gynecol, vol. 75, no. 4, pp. 594-9, 1990.
“Sensitivity, specificity, and positive predictive value of multiple malformations in isotretinoin embryopathy surveillance.”, Teratology, vol. 42, no. 5, pp. 513-9, 1990.
“Clinical-epidemiologic assessment of pattern of birth defects associated with human teratogens: application to diabetic embryopathy.”, Pediatrics, vol. 84, no. 4, pp. 658-65, 1989.
“Maternal cocaine use during early pregnancy as a risk factor for congenital urogenital anomalies.”, JAMA, vol. 262, no. 6, pp. 795-8, 1989.
